Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • PHARMACEUTICAL NEWS—DOJ proposes to reclassify marijuana as schedule III
    • ADMINISTRATION OF FDC ACT—FINAL RULES: FDA reclassifies ophthalmic device
    • COVID-19—Cal. App.: No amendment for dismissed taxpayer lawsuit claiming COVID-19 mRNA vaccines ‘are not vaccines’
    • DRUGS AND BIOLOGICS—FDA GUIDANCE NOTICES: Draft guidances provide product-specific recommendations
    • EXPERT INSIGHTS—DHHS bolsters non-discrimination protections for recipients of covered health care services and activities
    • GENERAL HEALTH CARE NEWS—D.C. Cir.: FOIA permits discovery of communications between agencies and Congress on health care reform
    • HEALTH CARE EMPLOYMENT ISSUES—S.D. W. Va.: Physician cannot apply WV Patient Safety Act retaliation claim to non-healthcare entity
    • HEALTH CARE REFORM NEWS: ASPE shares tool to assess successes in equity policies
    • REGULATION TRACKER—Information on pending or recently adopted regulations and regulation amendments
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Health Law Daily Wrap Up, REGULATION TRACKER—Information on pending or recently adopted regulations and regulation amendments, (May 20, 2024)

    By WK Editorial Staff

    This Health Law Regulation Tracker includes a Proposed Rules Comment Calendar and a Table of Final Rule Effective Dates.

    New proposed rules. On May 17, 2024, CMS issued a proposed rule that describes a new mandatory Medicare payment model, the Increas ...

    By WK Editorial Staff

    This Health Law Regulation Tracker includes a Proposed Rules Comment Calendar and a Table of Final Rule Effective Dates.

    New proposed rules. On May 17, 2024, CMS issued a proposed rule that describes a new mandatory Medicare payment model, the Increasing Organ Transplant Access Model (IOTA Model), that would test whether performance-based incentive payments paid to or owed by participating kidney transplant hospitals increase access to kidney transplants for patients with end-stage renal disease (ESRD) while preserving or enhancing the quality of care and reducing Medicare expenditures. This proposed rule also includes standard provisions that would apply to Innovation Center models whose first performance period begins on or after January 1, 2025, and also would apply, in whole or part, to any Innovation Center model whose first performance period begins prior to January 1, 2025 should such model’s governing documentation incorporate the provisions by reference in whole or in part. The proposed standard provisions relate to beneficiary protections; cooperation in model evaluation and monitoring; audits and records retention; rights in data and intellectual property; monitoring and compliance; remedial action; model termination by CMS; limitations on review; miscellaneous provisions on bankruptcy and other notifications; and the reconsideration review process.

    See the Regulation Tracker for details.

    New final rules. No new final rules have been issued since May 10, 2024.

    See the Regulation Tracker for details.

    IndustryNews: NewsStory AgencyNews ReimbursementNews CMSNews ESRDNews OrganNews HealthCare

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use